Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Narsoplimab for adult TA-TMA

Sergio Giralt • 22 Feb 2021
TCT 2021
General Narsoplimab

Sergio A. Giralt, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, explores the use of narsoplimab, an investigational MASP-2 inhibitor, currently evaluated for the treatment of adult transplant-associated thrombotic microangiopathy (TA-TMA). Recent studies have highlighted the efficacy of narsoplimab against TA-TMA, and Prof. Giralt discusses the promise of this agent. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from Sergio Giralt

How have the BMT CTN myeloma trials impacted clinical practice?
1:01
How have the BMT CTN myeloma trials impacted clinical practice?
Sergio Giralt • 2 Sep 2026
The recent expanded FDA approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
0:36
The recent expanded FDA approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
Sergio Giralt • 16 Apr 2024
Overcoming barriers to treating older patients with myeloma
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
The potentially curative role of CAR-T therapy in myeloma
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals